Segmental stiff skin syndrome treated with secukinumab

Segmental stiff skin syndrome is a rare fibrosing scleroderma‐like disorder characterized by progressive indurations of the skin leading to joint contractures, decreased mobility, and pain. Treatment options are limited; we report a patient that showed improvement with anti‐IL17 biologic therapy....

Full description

Saved in:
Bibliographic Details
Published in:Pediatric dermatology 2023-07, Vol.40 (4), p.738-739
Main Authors: Gelinas, Alexa, Powell, Julie, Lapointe, Chantal, Coulombe, Jerome
Format: Article
Language:English
Subjects:
biologic therapy
IL‐17
Interleukin 17
Monoclonal antibodies
Pediatrics
Scleroderma
secukinumab
segmental stiff skin syndrome
Skin
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Segmental stiff skin syndrome is a rare fibrosing scleroderma‐like disorder characterized by progressive indurations of the skin leading to joint contractures, decreased mobility, and pain. Treatment options are limited; we report a patient that showed improvement with anti‐IL17 biologic therapy.
ISSN:0736-8046
1525-1470
DOI:10.1111/pde.15274